Shanghai Rightongene Biotechnology Co Ltd Class A 688217
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- ¥12.95
- Day Range
- ¥12.96–13.47
- 52-Week Range
- ¥12.38–43.05
- Bid/Ask
- ¥13.17 / ¥13.18
- Market Cap
- ¥735.62 Mil
- Volume/Avg
- 3.1 Mil / 586,330
Key Statistics
- Price/Earnings (Normalized)
- 437.73
- Price/Sales
- 2.67
- Dividend Yield (Trailing)
- 1.37%
- Dividend Yield (Forward)
- 1.37%
- Total Yield
- 1.37%
Company Profile
Shanghai Rightongene Biotechnology Co Ltd is engaged in the research and development, production, sales, scientific research and testing services of in vitro diagnostic products.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Core
- Total Number of Employees
- 501
- Website
- http://www.rightongene.com
Comparables
Valuation
|
Metric
|
688217
|
688075
|
688253
|
|---|---|---|---|
Price/Earnings (Normalized) | 437.73 | 66.89 | 19.67 |
Price/Book Value | 0.79 | 0.82 | 2.35 |
Price/Sales | 2.67 | 8.32 | 7.49 |
Price/Cash Flow | 35.45 | — | 11.35 |
Price/Earnings
688217
688075
688253
Financial Strength
|
Metric
|
688217
|
688075
|
688253
|
|---|---|---|---|
Quick Ratio | 9.90 | 4.46 | 10.60 |
Current Ratio | 11.86 | 8.58 | 11.04 |
Interest Coverage | — | — | 1,693.02 |
Quick Ratio
688217
688075
688253
Profitability
|
Metric
|
688217
|
688075
|
688253
|
|---|---|---|---|
Return on Assets (Normalized) | 0.15% | 1.04% | 12.17% |
Return on Equity (Normalized) | 0.17% | 1.22% | 13.13% |
Return on Invested Capital (Normalized) | 0.16% | 1.21% | 12.68% |
Return on Assets
688217
688075
688253
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Novo Nordisk A/S ADR
NVO
| Wtcyhzzlpn | Wbjg | $565.6 Bil | |||
| Vertex Pharmaceuticals Inc
VRTX
| Mlkvysdg | Gzxgcp | $127.8 Bil | |||
| Regeneron Pharmaceuticals Inc
REGN
| Zrwvnffp | Kvxdct | $118.7 Bil | |||
| Moderna Inc
MRNA
| Dhrsqwkj | Dfxx | $46.8 Bil | |||
| Alnylam Pharmaceuticals Inc
ALNY
| Gyfmhztg | Fvnzjc | $29.7 Bil | |||
| argenx SE ADR
ARGX
| Msfgcgldv | Zsfhn | $29.3 Bil | |||
| BioNTech SE ADR
BNTX
| Nrzczdz | Fnmzq | $20.7 Bil | |||
| Biomarin Pharmaceutical Inc
BMRN
| Hkgbmptvl | Tlmqs | $16.1 Bil | |||
| United Therapeutics Corp
UTHR
| Plckqnjm | Jjhv | $15.0 Bil | |||
| Incyte Corp
INCY
| Dsqgtfhk | Qddqnt | $13.5 Bil |